John H Abeles's Net Worth

$45.3 Thousand

Estimate Recalculated Sep 8, 2024 07:21PM EST

Who is John H Abeles?

John H Abeles does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CombiMatrix Corp, Neurotrope, Inc., DUSA PHARMACEUTICALS INC, Medite Cancer Diagnostics, Inc., ORYX TECHNOLOGY CORP, ENCORE MEDICAL CORP, and I FLOW CORP /DE/.

SEC CIK

John H Abeles's CIK is 0000902418

Past Insider Trading and Trends

2015 was John H Abeles's most active year for acquiring shares with 6 total transactions. John H Abeles's most active month to acquire stocks was the month of December. 2005 was John H Abeles's most active year for disposing of shares, totalling 3 transactions. John H Abeles's most active month to dispose stocks was the month of December. 2005 saw John H Abeles paying a total of $94,475.00 for 40,000 shares, this is the most they've acquired in one year. In 2005 John H Abeles cashed out on 30,000 shares for a total of $150,030.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CombiMatrix Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 3
Form 4
∞
9.12K
—
—
9.12K
Apr 7
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jul 21
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Aug 15
Form 3
—
0
—
—
0
No matching records found

Neurotrope, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 13
Form 3
—
0
—
—
0
No matching records found

DUSA PHARMACEUTICALS INC No price found

Investor

John H Abeles owns 12,500 units of Common Stock. From 2006 to 2010 John H Abeles acquired a total of 32,500 shares in DUSA PHARMACEUTICALS INC at a cost of $104,725.00, John also disposed a total of 10,000 shares of DUSA PHARMACEUTICALS INC equalling to $150,030.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 30
Form 4/A
—
0
—
—
0
Form 4
+108.11%
40K
$1.28
$51,080.00
77K
Dec 16 - Dec 17
Form 4
—
0
—
—
0
Jun 30
Form 4
+150.00%
7.5K
—
—
12.5K
Mar 13
Form 4
—
0
—
—
0
Jun 30
Form 4
+4.57%
5K
$2.05
$10,250.00
114.5K
Nov 13
Form 4
—
0
—
—
0
Jun 30
Form 4/A
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 4
∞
10K
$9.86
-$55,555.00
10K
Jan 19 - Jan 20
Form 4
—
0
—
—
0
Jun 30
Form 4
+68.97%
10K
$2.90
$29,000.00
24.5K
Sep 22
Form 4
—
0
—
—
0
No matching records found

Medite Cancer Diagnostics, Inc. No price found

Investor

John H Abeles owns 10,000 units of Common Stock, $.001 par. From 2006 to 2018 John H Abeles acquired a total of 10,000 shares in Medite Cancer Diagnostics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+24.34%
306.67K
$0.08
—
1.57M
Aug 13 - Oct 11
Form 4
+18.11%
400K
$0.08
$30,000.00
2.61M
Jul 3
Form 4
∞
10K
—
—
10K
Jan 23
Form 4
—
0
—
—
0
Sep 28
No matching records found

ORYX TECHNOLOGY CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
4K
$1.63
$6,510.00
2.46K
Dec 6
Form 4
+9.58%
7.28K
$1.50
$10,917.00
83.22K
Jul 22
Form 4
+35.75%
20K
$2.50
$50,000.00
75.94K
Jan 29
Form 4
∞
20K
$1.00
$20,000.00
20K
Jul 28
No matching records found